Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

SABCS 2024 Summary: Key Updates From the EMBER-3, PATINA, TAILORx, I…

2024 SABCS Annual Meeting Insights Hub

M. Gatti-Mays

WCLC 2024 Insights: Optimal Management of Malignant Pleural Effusion

Insights from 2024 WCLC

P. Lee

ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-…

2024 ESMO Annual Meeting Insights Hub

P. Tarantino

Year in Review 2024 - NSCLC Perioperative Therapy

Oncology 2024 Year in Review

B. Halmos

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

2024 ESMO Annual Meeting Insights Hub

K. Natsuhara

The Non-Invasive Diagnosis of Lung Cancer

Memorial Sloan Kettering Cancer Center

G. Rocco

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

UNC Lineberger Comprehensive Cancer Center

A. Faso, B. Patel, K. Chen

Nodules and Lung Cancer Screening

Fox Chase Cancer Center

R. Kumar

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

Neoadjuvant vs. Adjuvant: A New Paradigm for NSCLC

Total Health

D. Carbone

Year in Review 2024 - Small Cell Lung Cancer

Nebraska Oncology Society

J. Murray

ESMO 2024 Summary: Key Trial Insights on Managing NSCLC With Low PD-…

ecancer

L. Paz-Ares

Thoracic Malignancies From an Interventional Pulmonologist's Perspec…

Fox Chase Cancer Center

C. Manley

The Use of IO Doublet in PD-L1-Negative NSCLC

David Carbone

Rad Onc 101: Radiation Oncology Basics

Nina Niu Sanford

N. Sanford

Adjuvant & Neoadjuvant Therapy in Early NSCLC With Actionable Genomi…

Fox Chase Cancer Center

J. Reuss

Year in Review 2024 - Key Trials and Progress in SCLC Treatment

Oncology 2024 Year in Review

N. Seetharamu

1L IO Advances in ES-SCLC Treatment

Fox Chase Cancer Center

A. Chiang

EGFRm Lung Cancer: Overview & Treatment Sequence

GRACE

J. Rotow